| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
| mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.09 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.09 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
| mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.1 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.1 |
| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |